-
Pfizer collaborates with DoctorOnCall to improve health literacy and patient care in Malaysia
prnasia
April 06, 2021
Pfizer announced its collaboration with DoctorOnCall to launch a digital therapeutics platform that focuses on three key therapeutic areas namely smoking cessation, vaccination, and heart health. Catering to an increasingly tech-savvy and ...
-
EU countries consent to share COVID-19 vaccines with member states in need
expresspharma
April 06, 2021
Those countries are Bulgaria, Croatia, Estonia, Latvia and Slovakia. They will also receive their pro-rata share of the total 10 million doses.
-
Pfizer and BioNTech’s Covid-19 vaccine shows 100% efficacy in adolescents
pharmaceutical-technology
April 02, 2021
Pfizer and BioNTech have reported that a Phase III trial of their Covid-19 vaccine, BNT162b2, showed 100% efficacy and strong antibody responses in adolescents aged 12 to 15 years with or without prior evidence of SARS-CoV-2 infection.
-
Pfizer COVID-19 vaccine safe, efficacious for adolescents
expresspharma
April 02, 2021
Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer.
-
Positive results for Pfizer/BioNTech’s COVID-19 vaccine in 12-15 year olds
pharmatimes
April 01, 2021
Pfizer and BioNTech have revealed positive top-line data for their COVID-19 vaccine – BNT162b2 – in adolescents aged 12 to 15 years old.
-
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
worldpharmanews
March 31, 2021
EMA's human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU.
-
First ever Award for Extraordinary Impact on Health bestowed on Moderna and Pfizer
europeanpharmaceuticalreview
March 31, 2021
While announcing 2021’s Top 10 Clinical Research Achievement Awards, the US Clinical Research Forum revealed that Pfizer and Moderna would be honoured for their COVID-19 vaccines.
-
COVID-19 vaccines from Pfizer, Moderna very effective after first shot: US real-world study
expresspharma
March 31, 2021
The risk of infection fell 90 per cent by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and first responders found.
-
WHO issues alert for falsified COVID-19 vaccine
europeanpharmaceuticalreview
March 30, 2021
The World Health Organization (WHO) has warned that a falsified COVID-19 vaccine, identified as Pfizer’s BNT162b2, could still be in circulation in the Americas.
-
FDA panel votes against Pfizer’s tanezumab for osteoarthritis pain
pharmaceutical-technology
March 29, 2021
A joint FDA advisory committee has rejected a risk mitigation proposal for Pfizer and Eli Lilly’s osteoarthritis (OA) drug tanezumab, concluding that the drug’s safety risk to patients is too high.